Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Devices

BioTelemetry Inc

+ Add to Watchlist

BEAT:US

9.7600 USD 0.2400 2.52%

As of 15:59:01 ET on 05/27/2015.

Snapshot for BioTelemetry Inc (BEAT)

Open: 9.5300 Day's Range: 9.4300 - 9.7800 Volume: 101,829
Previous Close: 9.5200 52wk Range: 6.4400 - 11.3300 1-Yr Rtn: +34.25%

Stock Chart for BEAT

No chart data available.
  • BEAT:US 9.7600
  • 1D
  • 1M
  • 1Y
9.5200
Interactive BEAT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BEAT

Current P/E Ratio (ttm) 38.1957
Estimated P/E(12/2015) 24.4304
Relative P/E vs. SPX 2.0756
Earnings Per Share (USD) (ttm) 0.2529
Est. EPS (USD) (12/2015) 0.3950
Est. PEG Ratio 0.8143
Market Cap (M USD) 261.32
Shares Outstanding (M) 27.05
30 Day Average Volume 171,385
Price/Book (mrq) 4.1262
Price/Sale (ttm) 1.4964
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/31/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BEAT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BEAT

BioTelemetry, Inc. provides ambulatory outpatient management solutions for monitoring clinical information regarding an individual's health. The Company's initial efforts are focused on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders.

Joseph H Capper "Joe"President/CEOHeather C GetzSenior VP/CFO
Michael D GeldartSenior VP:Bus Dev/COOPeter FerolaSenior VP:Corporate Dev/Secy
More Company Profile & Key Executives for BEAT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil